Compare Ginkgo Bioworks Holdings Inc (DNA) vs Nuwellis Inc (NUWE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ginkgo Bioworks Holdings Inc vs Nuwellis Inc — how do they compare? Ginkgo Bioworks Holdings Inc trades at $7.51 (market cap $505.73M), while Nuwellis Inc trades at $1.49 (market cap $542.80K). The key difference: Ginkgo Bioworks Holdings Inc is far larger — about 931.7× Nuwellis Inc's market cap, and Ginkgo Bioworks Holdings Inc is trading nearer its 52-week high, Nuwellis Inc nearer its low. Which is the better fit depends on your goals.
| DNA | NUWE | |
|---|---|---|
Market Cap | $505.73M | $542.80K |
Sector | Health | Technology |
52-Week High | $16.14 | $220.50 |
52-Week Low | $5.48 | $1.42 |
Enterprise Value | $607.68M | -$1.27M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Ginkgo Bioworks Holdings Inc
Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.
Read more on DNA →About Nuwellis Inc
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →
